Keren Leshem - Board Member of Aspivix

Keren Leshem

Chief Executive Officer at OCON Therapeutics

I’m currently the CEO and a Director/Board Member at OCON healthcare.  An innovative women’s health company with a mission to introduce safer intrauterine drug-delivery technology to improve and impact women’s health and quality of life.

I was honored to be featured in FORBES magazine as one of 3 women shaping the future of women’s health, I’ve recently been invited to the World Economic Forum as a technology pioneer and named 1 of 100 women of influence by Entrepreneur magazine.

I’m a Board director at a Swiss company: ASPIVIX, I’m a steering commitee member with the NIH - Bill & Melinda Gates Foundation IEF (Innovation Equity Forum), I‘ve joined UK’s FemTech Lab’s admissions and advisory Board as well as LSX’s Advisory Board and I’m a Mentor at the Israeli 8400 Healthtech Network program.

Prior to OCON I served as VP Corporate Development at the European pharma company VISUfarma served as a board member of a BioLight (TASE: BOLT) company: ViSci (which I previously headed as CEO) and was a University lecturer in Marketing & Business English.

As the founder & CEO of ViSci Ltd (Licensed from NASDQ: AERI) & CEO of AOPharma, I successfully led Clinical, R&D and BD activities (FDA: 505(b)(2) & 510K) that included GMP Manufacturing, CMC, Regulatory & Clinical Operations) to achieve commercial status and MTAs (Material Transfer Agreements) including fund raising close to $100M in the various roles.

I believe in strengthening women and I make sure to lead with passion, integrity and focus on my brilliant team of (mostly) women, service providers and customers. I make sure to donate my time and my earnings to and with women that are starting out their career path and those whom have made choices that require mentoring.  I love what I do and I do what I love.

Meet our other board members: